MYRIAD GENETICS, INC. - 12/31/2020

Company

MYRIAD GENETICS INC

Filed

February 16, 2021

Accession Number

0001102578-21-000035

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →